EUVIMEDEUVIMED entdecken
Crossref

Unspecified degradation impurities identification and characterization in bilastine and montelukast tablet formulations by using UPLC and LCMS/MS: Robustness by design expert and green assessment

Raj Kumar Kodishala, Kousrali Sayyad, Leela Prasad Kowtharapu, Naresh Konduru, Tanmoy Mondal, Mohan Varkolu, Sreedhar Gundekari

Annales Pharmaceutiques Françaises · 2025-11 · 83 (6) · 1092-1113

DOI: 10.1016/j.pharma.2025.04.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2025-11. Verfasst von Raj Kumar Kodishala und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Koneru Lakshmaiah Education Foundation, Aziznagar, Hyderabad, Telangana 500075, India. Hauptthemen laut MEDLINE: Quinolines, Drug Contamination, Acetates, Piperidines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study introduces a novel ultra-performance liquid chromatography (UPLC) method for the rapid, simple, and accurate detection of contaminants in bilastine (BLS) and montelukast (MTK) tablet formulations. MATERIAL AND METHODS: The separation of BLS impurity-A, BLS impurity-B, BLS, MTK impurity-A, MTK, and MTK impurity-B was achieved using an Acquity BEH C18 column (50×2.1mm, 1.7μm) under gradient eluent conditions. The mobile phases consisted of 0.1% triethylamine in water with the pH adjusted to 2.5 using orthophosphoric acid (mobile phase A) and acetonitrile (mobile phase B). The ratio of mobile phase A to B was 70:30 (v/v). The column flow rate was set at 0.2mL/min, and the photodiode array detector (PDA) was used to quantify the analytes. The detection wavelength was set to 224nm. RESULTS: In a runtime of just 20minutes, 13 analytes were successfully separated. The retention times for the target compounds and impurities were as follows: BLS impurity-A: 1509min, BLS impurity-B: 3435min, BLS: 5668min, MTK impurity-A: 8137min, MTK: 9784min, MTK impurity-B: 11,853min. The unspecified impurities in the degradation samples were detected at retention times of 2174, 2657, 3368, 4143, 8239, 11,722, and 12,436minutes, and were characterized using liquid chromatography-mass spectrometry (LC-MS). CONCLUSION: The UPLC-based analytical method demonstrated in this study is an effective and efficient technique for the quantification of BLS, MTK, and their associated impurities in tablet formulations. This method has been validated in accordance with ICH Q2(R2) and USP guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesDrug ContaminationAcetatesPiperidinesBenzimidazolesTabletsSulfidesChromatography, High Pressure LiquidCyclopropanesTandem Mass SpectrometryGreen Chemistry TechnologyChromatography, LiquidReproducibility of ResultsChemistry, PharmaceuticalDrug Stability

Stichwörter der Autor:innen

BilastineChromatographie liquide ultra-performanteDégradation forcéeForced degradationImpuretésImpuritiesLiquid chromatography mass spectrometerMontelukastSpectromètre de masse pour chromatographie liquideUltra-performance liquid chromatography

Substanzen

montelukastQuinolinesTabletsAcetatesSulfidesCyclopropanesbilastinePiperidinesBenzimidazoles

Autor:innen und Institutionen

  • Department of Chemistry, Koneru Lakshmaiah Education Foundation, Aziznagar, Hyderabad, Telangana 500075, India.
  • GITAM Deemed to be University, Department of Chemistry, School of Science, Hyderabad, Telangana 502329, India.
  • Department of Chemistry, Koneru Lakshmaiah Education Foundation, Aziznagar, Hyderabad, Telangana 500075, India. Electronic address: sreedhar.gundekari@gmail.com.

Zitieren

APA

Kodishala, R. K., Sayyad, K., Kowtharapu, L. P., Konduru, N., Mondal, T., Varkolu, M., & Gundekari, S. (2025). Unspecified degradation impurities identification and characterization in bilastine and montelukast tablet formulations by using UPLC and LCMS/MS: Robustness by design expert and green assessment. Annales Pharmaceutiques Françaises, 83(6), 1092-1113. https://doi.org/10.1016/j.pharma.2025.04.006

Vancouver

Kodishala RK, Sayyad K, Kowtharapu LP, Konduru N, Mondal T, Varkolu M, et al. Unspecified degradation impurities identification and characterization in bilastine and montelukast tablet formulations by using UPLC and LCMS/MS: Robustness by design expert and green assessment. Annales Pharmaceutiques Françaises. 2025;83(6):1092-1113. doi:10.1016/j.pharma.2025.04.006

BibTeX
@article{Kodishala2025,
  author = {Kodishala, Raj Kumar and Sayyad, Kousrali and Kowtharapu, Leela Prasad and Konduru, Naresh and Mondal, Tanmoy and Varkolu, Mohan and Gundekari, Sreedhar},
  title = {Unspecified degradation impurities identification and characterization in bilastine and montelukast tablet formulations by using UPLC and LCMS/MS: Robustness by design expert and green assessment},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2025},
  volume = {83},
  number = {6},
  pages = {1092--1113},
  doi = {10.1016/j.pharma.2025.04.006}
}
Kostenlos starten →